Some patients with confirmed HCC may still exhibit normal AFP levels, leading to a substantial risk of missed diagnosis.[13] To overcome this limitation, novel biomarkers such as SAA and CRP have received increasing attention. This evidence concerns the gene AFP and hepatocellular carcinoma.